Companies:
53,025
Total Market Cap:
168993657296421.08
Enlivex Therapeutics Ltd.
NASDAQ: ENLV
Healthcare
Biotechnology
Global Rank
#21260
Country Rank
#282
Market Cap
204.89 M
Price
0.85
Change (%)
0.01%
Volume
490,067
Enlivex Therapeutics Ltd.'s latest marketcap:
204.89 M
As of 06/04/2026, Enlivex Therapeutics Ltd.'s market capitalization has reached $204.89 M. According to our data, Enlivex Therapeutics Ltd. is the 21260th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 204.89 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 1.24 B |
| Shares Out | 241.05 M |
| EPS (ttm) | 25.48 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 06/15/2026 |
Market Cap Chart
Data Updated: 06/04/2026
Enlivex Therapeutics Ltd.'s yearly market capitalization.
Enlivex Therapeutics Ltd. has seen its market value grow from $83.1 M to $204.89 M since 2014, representing a total increase of 146.56% and an annual compound growth rate (CAGR) of 8.22%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/04/2026 | $204.89 M | 24.68% | 21260 |
| 12/31/2025 | $166.93 M | 548.82% | 34143 |
| 12/31/2024 | $25.73 M | -48.77% | 32515 |
| 12/29/2023 | $50.22 M | -30.73% | 27729 |
| 12/30/2022 | $72.5 M | -36.72% | 24362 |
| 12/31/2021 | $114.57 M | 31.53% | 22242 |
| 12/31/2020 | $87.1 M | 2388.57% | 21405 |
| 12/31/2019 | $3.5 M | 34.62% | 31449 |
| 12/31/2018 | $2.6 M | -65.33% | 30957 |
| 12/29/2017 | $7.5 M | -49.32% | 28302 |
Company Profile
Enlivex Therapeutics Ltd. was founded in 2005 in Israel.
The company went public on 12/12/1995
on the Nasdaq Stock Market.
With 34 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Enlivex Therapeutics Ltd.'s (ENLV) current market cap?As of 06/04/2026, Enlivex Therapeutics Ltd. (including the parent company, if applicable) has an estimated market capitalization of $204.89 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Enlivex Therapeutics Ltd. (ENLV) rank globally by market cap?Enlivex Therapeutics Ltd. global market capitalization ranking is approximately 21260 as of 06/04/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.